Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Takiuchi H, Goto M, Imamura H, Furukawa H, Imano M, Imamoto H, Kimura Y, Ishida H, Fujitani K, Narahara H, Shimokawa T. Takiuchi H, et al. Among authors: narahara h. Jpn J Clin Oncol. 2008 Mar;38(3):176-81. doi: 10.1093/jjco/hyn003. Epub 2008 Feb 16. Jpn J Clin Oncol. 2008. PMID: 18281707 Clinical Trial.
Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).
Takiuchi H, Narahara H, Tsujinaka T, Gotoh M, Kawabe S, Katsu K, Iishi H, Tatsuta M, Fujitani K, Furukawa H, Taguchi T; Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG). Takiuchi H, et al. Among authors: narahara h. Jpn J Clin Oncol. 2005 Sep;35(9):520-5. doi: 10.1093/jjco/hyi148. Epub 2005 Sep 1. Jpn J Clin Oncol. 2005. PMID: 16141295 Clinical Trial.
A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: a new concept of clinical benefit response for non-measurable type of gastric cancer.
Sakamoto J, Morita S, Yumiba T, Narahara H, Kinoshita K, Nakane Y, Imamoto H, Shiozaki H; Ascitic Gastric Cancer Study Group of the Japan South West Oncology Group. Sakamoto J, et al. Among authors: narahara h. Jpn J Clin Oncol. 2003 May;33(5):238-40. doi: 10.1093/jjco/hyg048. Jpn J Clin Oncol. 2003. PMID: 12865468 Clinical Trial.
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer.
Imamoto H, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, Morimoto T, Nakamura M, Oriuchi N, Kakutani C, Morita S, Shiozaki H. Imamoto H, et al. Among authors: narahara h. Gastric Cancer. 2011 Mar;14(1):81-90. doi: 10.1007/s10120-011-0016-6. Epub 2011 Feb 17. Gastric Cancer. 2011. PMID: 21327925 Clinical Trial.
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
Narahara H, Iishi H, Imamura H, Tsuburaya A, Chin K, Imamoto H, Esaki T, Furukawa H, Hamada C, Sakata Y. Narahara H, et al. Gastric Cancer. 2011 Mar;14(1):72-80. doi: 10.1007/s10120-011-0009-5. Epub 2011 Feb 23. Gastric Cancer. 2011. PMID: 21340666 Free PMC article. Clinical Trial.
325 results